Berkshire Money Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-346
Closed -$371K 88
2025
Q4
$371K Buy
+346
New +$331K 0.04% 85
2025
Q3
Sell
-312
Closed -$243K 92
2025
Q2
$243K Buy
312
+2
+0.6% +$1.55K 0.03% 90
2025
Q1
$256K Sell
310
-81
-21% -$67.4K 0.03% 84
2024
Q4
$302K Buy
+391
New +$324K 0.03% 72

Other funds holding LLY

Berkshire Money Management's LLY Position: Q1 2026 in Review

Berkshire Money Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 346 shares — an estimated $371K sold.

Berkshire Money Management first reported a position in LLY in Q4 2024 and held it in 4 quarters. The position peaked at $371K in Q4 2025. 4,358 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Berkshire Money Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Berkshire Money Management sold 346 Eli Lilly shares in Q1 2026, an estimated $371K.
  • Berkshire Money Management first reported a position in Eli Lilly in Q4 2024 and held it in 4 quarters.
  • Berkshire Money Management's Eli Lilly position peaked at $371K in Q4 2025.
  • 4,358 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Berkshire Money Management's 13F filing for Q1 2026, filed 21 Apr 2026.